Andrea Meredith, Ph.D., is a neuroscientist and rare disease advocate.  Dr. Meredith is a Professor of Physiology at the University of Maryland School of Medicine in Baltimore, where she heads the KCNMA1 Translational Research Laboratory, an NIH-funded pre-clinical research lab studying neurogenetic disease.  Her research has established the clinical manifestations, mechanistic underpinnings, and gene variant-delineated treatment for KCNMA1 channelopathy, an ultra-rare seizure and dyskinesia disorder resulting from aberrant electrical signaling in the brain and muscles.  She has authored over 60 peer-reviewed publications and co-founded the KCNMA1 International Advocacy Foundation (KCIAF).  Dr. Meredith works with clinical, NIH, industry, and patient partners and stakeholders to raise awareness of channelopathy disorders. She serves on numerous NIH scientific review panels, scientific advisory boards, and patient advocacy committees and participates in many types of outreach activities that educate the public about brain health and neurological disorders.